开发细胞因子装甲CAR T细胞的进展
Krishneel Prasad1,2, Ryan S Cross1,2, Misty R Jenkins3,4
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Nature reviews. Immunology
|March 6, 2026
概括
第四代化学抗原受体 (CAR) T细胞被设计为共表达细胞因子,增强固体瘤治疗的疗效和持续性. 策略侧重于有条件的细胞因子释放,以尽量减少系统性毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) T 细胞疗法已经从第一代到第四代结构显著进步.
- 第四代CAR T细胞,称为"装甲"CAR T细胞,是为了增强抗瘤活性而设计的.
研究的目的:
- 探索细胞因子增强的CAR T细胞的临床和临床前发现.
- 讨论条件性细胞因子分泌的策略,以提高安全性和疗效.
主要方法:
- 改造CAR T细胞以共同表达细胞因子,化学因子和其他免疫调节因子.
- 在瘤微环境中对细胞因子增强的CAR T细胞结构的临床前和临床评估.
主要成果:
- 细胞因子联合表达旨在提高CAR T细胞的疗效,安全性和持久性.
- 在瘤微环境中,免疫抑制的逆转潜力.
- 条件性细胞因子分泌策略正在开发中,以减轻系统性毒性.
结论:
- 细胞因子增强的CAR-T细胞通过克服免疫抑制来治疗固体瘤有希望.
- 对条件性细胞因子释放的进一步研究对于安全有效的临床应用至关重要.
相关概念视频
T Cell Activation and Clonal Selection
16.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.9K
T Cell Types and Functions
3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


